Effect of Coronary Thrombus Aspiration in Non ST Elevation Acute Coronary Syndrome Patients on Three-Year Survival- Does it add any Benefit?
dc.contributor.author | Yildiz B.S. | |
dc.contributor.author | Cetin N. | |
dc.contributor.author | Gunduz R. | |
dc.contributor.author | Bilge A. | |
dc.contributor.author | Ozgur S. | |
dc.contributor.author | Orman M.N. | |
dc.date.accessioned | 2024-07-22T08:04:11Z | |
dc.date.available | 2024-07-22T08:04:11Z | |
dc.date.issued | 2022 | |
dc.description.abstract | We assessed the effect of thrombus aspiration (TA) during percutaneous coronary intervention (PCI) on in-hospital and 3-year mortality in consecutive non-ST segment elevation myocardial infarction (n = 189) and unstable angina pectoris (n = 148) patients (n = 337) between 2011 and 2016. In total, 153 patients (45.4%) underwent TA. The number of patients with postoperative thrombolysis in terms of myocardial infarction grade 3 blood flow (P <.001) and myocardial blush grade 3 (P <.001) were significantly higher in all TA groups. At 6-, 12- and 24-month post-PCI, the mean left ventricular ejection fraction was significantly higher in the all TA groups versus the stand alone PCI group (P <.001). Thrombus aspiration was associated with a significant improvement both in epicardial flow, myocardial perfusion and left ventricular ejection fraction. Thrombus aspiration during PCI in all acute coronary syndrome (except ST segment elevation) patients was associated with better survival compared with stand alone PCI group at 3-year follow-up (P =.019). © The Author(s) 2022. | |
dc.identifier.DOI-ID | 10.1177/00033197211053404 | |
dc.identifier.issn | 00033197 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12573 | |
dc.language.iso | English | |
dc.publisher | SAGE Publications Inc. | |
dc.subject | Acute Coronary Syndrome | |
dc.subject | Coronary Angiography | |
dc.subject | Coronary Thrombosis | |
dc.subject | Humans | |
dc.subject | Percutaneous Coronary Intervention | |
dc.subject | Stroke Volume | |
dc.subject | Thrombectomy | |
dc.subject | Treatment Outcome | |
dc.subject | Ventricular Function, Left | |
dc.subject | acetylsalicylic acid | |
dc.subject | angiotensin receptor antagonist | |
dc.subject | anticoagulant agent | |
dc.subject | antilipemic agent | |
dc.subject | antithrombocytic agent | |
dc.subject | beta adrenergic receptor blocking agent | |
dc.subject | C reactive protein | |
dc.subject | calcium channel blocking agent | |
dc.subject | clopidogrel | |
dc.subject | dipeptidyl carboxypeptidase inhibitor | |
dc.subject | fibrinogen receptor antagonist | |
dc.subject | glyceroltrinitrate | |
dc.subject | hemoglobin | |
dc.subject | heparin | |
dc.subject | nitrate | |
dc.subject | prasugrel | |
dc.subject | troponin I | |
dc.subject | unclassified drug | |
dc.subject | acute kidney failure | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | algorithm | |
dc.subject | angiography | |
dc.subject | arteriovenous fistula | |
dc.subject | artery catheterization | |
dc.subject | Article | |
dc.subject | atrial fibrillation | |
dc.subject | balloon dilatation | |
dc.subject | bleeding | |
dc.subject | blood clot lysis | |
dc.subject | blood flow | |
dc.subject | brain hemorrhage | |
dc.subject | cardiogenic shock | |
dc.subject | cardiovascular disease | |
dc.subject | carotid arteriography | |
dc.subject | cerebrovascular accident | |
dc.subject | cohort analysis | |
dc.subject | congestive heart failure | |
dc.subject | controlled study | |
dc.subject | coronary angiography | |
dc.subject | coronary artery blood flow | |
dc.subject | coronary artery perforation | |
dc.subject | coronary dissection | |
dc.subject | echocardiography | |
dc.subject | epicardial flow | |
dc.subject | estimated glomerular filtration rate | |
dc.subject | feasibility study | |
dc.subject | female | |
dc.subject | follow up | |
dc.subject | GRACE risk score | |
dc.subject | heart infarction | |
dc.subject | heart left bundle branch block | |
dc.subject | heart left ventricle ejection fraction | |
dc.subject | heart left ventricle volume | |
dc.subject | heart muscle perfusion | |
dc.subject | heart right bundle branch block | |
dc.subject | heart tamponade | |
dc.subject | heart ventricle fibrillation | |
dc.subject | heart ventricle tachycardia | |
dc.subject | hematoma | |
dc.subject | human | |
dc.subject | intraocular hemorrhage | |
dc.subject | life expectancy | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | medical ethics | |
dc.subject | middle aged | |
dc.subject | non st segment elevation acute coronary syndrome | |
dc.subject | non ST segment elevation myocardial infarction | |
dc.subject | observational study | |
dc.subject | percutaneous coronary intervention | |
dc.subject | retrospective study | |
dc.subject | ST segment elevation myocardial infarction | |
dc.subject | stent implantation | |
dc.subject | stent thrombosis | |
dc.subject | survival analysis | |
dc.subject | SYNTAX score | |
dc.subject | target lesion revascularization | |
dc.subject | target vessel revascularization | |
dc.subject | thrombectomy | |
dc.subject | thrombus aspiration | |
dc.subject | unstable angina pectoris | |
dc.subject | very elderly | |
dc.subject | acute coronary syndrome | |
dc.subject | adverse event | |
dc.subject | complication | |
dc.subject | coronary artery thrombosis | |
dc.subject | heart left ventricle function | |
dc.subject | heart stroke volume | |
dc.subject | percutaneous coronary intervention | |
dc.subject | treatment outcome | |
dc.title | Effect of Coronary Thrombus Aspiration in Non ST Elevation Acute Coronary Syndrome Patients on Three-Year Survival- Does it add any Benefit? | |
dc.type | Article |